FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 104 filers reported holding FATE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,602,312 | -59.4% | 158,802 | -9.9% | 0.00% | -75.0% |
Q3 2022 | $3,949,000 | +15.2% | 176,204 | +27.4% | 0.00% | +33.3% |
Q2 2022 | $3,428,000 | -36.1% | 138,348 | 0.0% | 0.00% | -25.0% |
Q1 2022 | $5,364,000 | -43.0% | 138,348 | -14.0% | 0.00% | -33.3% |
Q4 2021 | $9,417,000 | -12.4% | 160,945 | -11.3% | 0.01% | -25.0% |
Q3 2021 | $10,754,000 | -30.7% | 181,447 | +1.5% | 0.01% | -33.3% |
Q2 2021 | $15,512,000 | +4.1% | 178,725 | -1.1% | 0.01% | +9.1% |
Q1 2021 | $14,897,000 | -5.2% | 180,677 | +4.5% | 0.01% | -8.3% |
Q4 2020 | $15,721,000 | +142.7% | 172,887 | +6.7% | 0.01% | +100.0% |
Q3 2020 | $6,478,000 | +36.3% | 162,080 | +17.0% | 0.01% | +20.0% |
Q2 2020 | $4,753,000 | +58.3% | 138,520 | +2.5% | 0.01% | +25.0% |
Q1 2020 | $3,002,000 | +23.8% | 135,146 | +9.0% | 0.00% | +100.0% |
Q4 2019 | $2,425,000 | +2.1% | 123,935 | -19.0% | 0.00% | 0.0% |
Q3 2019 | $2,375,000 | +94.0% | 152,914 | +153.6% | 0.00% | +100.0% |
Q2 2019 | $1,224,000 | +27.1% | 60,286 | +10.0% | 0.00% | 0.0% |
Q1 2019 | $963,000 | +28.9% | 54,816 | -5.8% | 0.00% | 0.0% |
Q4 2018 | $747,000 | -21.2% | 58,184 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $948,000 | +391.2% | 58,184 | +242.4% | 0.00% | – |
Q2 2018 | $193,000 | – | 16,993 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $83,733,000 | 21.39% |
Redmile Group, LLC | 12,957,222 | $321,080,000 | 12.26% |
GCM Grosvenor Holdings, LLC | 1,037,256 | $25,703,000 | 5.81% |
Casdin Capital, LLC | 2,100,000 | $52,038,000 | 4.40% |
Ally Bridge Group (NY) LLC | 181,500 | $4,498,000 | 4.10% |
DAFNA Capital Management LLC | 550,940 | $13,652,000 | 3.72% |
Artal Group S.A. | 2,600,000 | $64,428,000 | 3.44% |
Deep Track Capital, LP | 2,018,005 | $50,006,000 | 3.29% |
HighVista Strategies LLC | 118,778 | $2,943,000 | 1.78% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,917 | $158,000,000 | 1.65% |